Breaking News Instant updates and real-time market news.

ISRG

Intuitive Surgical

$721.73

12.29 (1.73%)

07:20
10/19/16
10/19
07:20
10/19/16
07:20

Intuitive Surgical price target raised to $800 from $750 at Canaccord

Canaccord analyst Jason Mills raised his price target on Intuitive Surgical to $800 from $750 following "blowout" Q3 results. The analyst cited strong robotic growth, expectations for improved gross margins, procedure growth, and improving revenue per procedure. Mills reiterated his Buy rating on Intuitive Surgical shares.

  • 21

    Oct

  • 29

    Nov

ISRG Intuitive Surgical
$721.73

12.29 (1.73%)

09/19/16
LEER
09/19/16
NO CHANGE
Target $780
LEER
Outperform
Leerink positive on Intuitive Surgical's hernia opportunity
Leerink analyst Richard Newitter says he left this weekend's Annual Global Symposium on Robotic-Assisted and Minimally Invasive Hernia Repair "incrementally more positive" on the adoption outlook for Intuitive Surgical's robotic hernia category. Hernia can remain a source of upside for the company's gen surgery division, Newitter tells investors in a research note. He reiterates an Outperform rating on the shares with a $780 price target.
09/20/16
SBSH
09/20/16
NO CHANGE
Target $779
SBSH
Buy
Intuitive Surgical procedure upside looks likely, says Citi
Following his firm's semi-annual urology survey and gynecology survey, Citi analyst Amit Hazan believes more procedure upside for Intuitive Surgical looks likely. The results point to continued strength in Intuitive's legacy categories that make up nearly 70% of its U.S. procedures, Hazan tells investors in a research note. He keeps a Buy rating on the shares with a $779 price target.
10/13/16
WELS
10/13/16
INITIATION
WELS
Outperform
Intuitive Surgical initiated with an Outperform at Wells Fargo
Wells Fargo analyst Larry Biegelsen started Intuitive Surgical with an Outperform rating and $815-$825 price target range. The analyst expects continued adoption of hernia repair and colorectal procedures to drive "strong growth" in the United States and views the company's international opportunity as underappreciated. Biegelsen sees "several reasons" for why Intuitive's share outperformance to continue.
10/19/16
PIPR
10/19/16
NO CHANGE
Target $700
PIPR
Neutral
Intuitive Surgical Q3 results likely not enough, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien says Intuitive Surgical's Q3 results, while better than expected, are likely not enough to keep the stock from "falling a bit" today given the year-to-date rally. The analyst does not recommend selling the shares, however, as he does not see any "meaningfully concerning issues for the story." At the same time, O'Brien does not suggest putting new money to work given the "premium valuation." He keeps a Neutral rating on Intuitive Surgical with a $700 price target.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.